P53 Gene Mutations Occurring in Spontaneous Benign and Malignant Mammary Tumors of the Dog
Overview
Veterinary Medicine
Affiliations
Sixty-three cases of benign and malignant canine mammary tumors were analyzed to define the alteration of exons 5-8 for the p53 tumor suppressor gene using polymerase chain reaction direct sequence analysis with paraffin-embedded tissues. Four missense mutations were found in 38 benign mammary tumors (11%), and five missense (one tumor had two missense mutations) and one nonsense mutations were found in 25 mammary carcinomas (20%). These data suggest that the p53 gene alterations might be initiated at an early stage of canine mammary carcinogenesis and p53 mutations might be associated with malignancy. However, there was no evidence of any relationship between the p53 alterations and the histologic types of tumors or breeds of dogs.
Bhutta Z, Choi K Arch Pharm Res. 2025; 48(1):43-61.
PMID: 39752109 DOI: 10.1007/s12272-024-01524-y.
Guil-Luna S, Sanchez-Cespedes R, Crespo A, Dolores Fernandez M, Fernandez Sarmiento J, Rodriguez-Ariza A Front Vet Sci. 2023; 10:1157878.
PMID: 37065257 PMC: 10090457. DOI: 10.3389/fvets.2023.1157878.
Canine as a Comparative and Translational Model for Human Mammary Tumor.
Kwon J, Moskwa N, Kang W, Fan T, Lee C J Breast Cancer. 2023; 26(1):1-13.
PMID: 36762784 PMC: 9981990. DOI: 10.4048/jbc.2023.26.e4.
Goto M, Hirata A, Murakami M, Sakai H J Vet Med Sci. 2019; 81(12):1791-1803.
PMID: 31597817 PMC: 6943331. DOI: 10.1292/jvms.19-0469.
Canine mammary tumors as a model for human disease.
Abdelmegeed S, Mohammed S Oncol Lett. 2018; 15(6):8195-8205.
PMID: 29928319 PMC: 6004712. DOI: 10.3892/ol.2018.8411.